Structure-activity relationship of GSK-3β inhibitors: insight into drug design for Alzheimer's disease.

Journal: RSC medicinal chemistry •

Abstract

Abstract text is not embedded in this discovery record. Please consult the full-text publication via the source link on the right.

Subjects & Keywords

How to Cite this Article

Rajamani G, Naqvi S, Sharma A (2026). "Structure-activity relationship of GSK-3β inhibitors: insight into drug design for Alzheimer's disease.". RSC medicinal chemistry. https://doi.org/10.1039/d5md00211g